Sunitinib versus interferon alfa in metastatic renal-cell carcinoma (mRCC): updated efficacy and safety results and further analysis of prognostic factors - Motzer, R J; Michaelson, M D; Hutson, T E (Eur J Cancer, 2007)
et al.